167 related articles for article (PubMed ID: 35195557)
1. Prognostic Significance of Systemic Inflammation Indices by K-ras Status in Patients With Metastatic Colorectal Cancer.
Miyamoto Y; Akiyama T; Kato R; Sawayama H; Ogawa K; Yoshida N; Baba H
Dis Colon Rectum; 2023 Aug; 66(8):e809-e817. PubMed ID: 35195557
[TBL] [Abstract][Full Text] [Related]
2. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Nutritional Scores as Host-Related Prognostic Factors for Both Overall Survival and Postoperative Complications in Patients With Stage II to III Colorectal Cancer.
Ahiko Y; Shida D; Nakamura Y; Imaizumi J; Takamizawa Y; Moritani K; Tsukamoto S; Kanemitsu Y
Dis Colon Rectum; 2021 Oct; 64(10):1222-1231. PubMed ID: 33951689
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Enlarged Lymph Nodes in Stage II Colorectal Cancer.
Matsunaga K; Sasaki K; Nozawa H; Kawai K; Murono K; Yamauchi S; Sugihara K; Ishihara S
Dis Colon Rectum; 2023 Nov; 66(11):e1097-e1106. PubMed ID: 37603828
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Characteristics of Patients With Colorectal Cancer Who Have Benign Mesenteric Lymph Node Enlargement: A Multi-institutional Cohort Study.
Huang X; Yang Y; Liu Q; Tang X; Shi J; Qu H; Chen X; Gong L; Wang S; Tang S; Wang P; Tang L; Hu D; Yin X; Guan Y; Kong D; Tian F
Dis Colon Rectum; 2022 Jun; 65(6):804-816. PubMed ID: 34759241
[TBL] [Abstract][Full Text] [Related]
7. Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
Kyong Shin J; Ah Park Y; Wook Huh J; Hyeon Yun S; Cheol Kim H; Yong Lee W; Hyung Kim S; Yun Ha S; Cho YB
Dis Colon Rectum; 2023 Aug; 66(8):e801-e808. PubMed ID: 35394982
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
Dis Colon Rectum; 2023 Jul; 66(7):905-913. PubMed ID: 35195558
[TBL] [Abstract][Full Text] [Related]
9. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
[TBL] [Abstract][Full Text] [Related]
10. Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients With Colorectal Cancer After Surgical Resection.
Kusunoki K; Toiyama Y; Okugawa Y; Yamamoto A; Omura Y; Ohi M; Araki T; Kusunoki M
Dis Colon Rectum; 2020 Sep; 63(9):1242-1250. PubMed ID: 33216495
[TBL] [Abstract][Full Text] [Related]
11. Risk Stratification Using Neoadjuvant Rectal Score in the Era of Neoadjuvant Chemoradiotherapy: Validation With Long-term Outcome Data.
Lim YJ; Song C; Jeon SH; Kim K; Chie EK
Dis Colon Rectum; 2021 Jan; 64(1):60-70. PubMed ID: 33306532
[TBL] [Abstract][Full Text] [Related]
12. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
[TBL] [Abstract][Full Text] [Related]
13. Value of the Tumor-Stroma Ratio and Structural Heterogeneity Measured by a Novel Semiautomatic Image Analysis Technique for Predicting Survival in Patients With Colon Cancer.
Inoue H; Kudou M; Shiozaki A; Kosuga T; Shimizu H; Kiuchi J; Arita T; Konishi H; Komatsu S; Kuriu Y; Morinaga Y; Konishi E; Otsuji E
Dis Colon Rectum; 2023 Nov; 66(11):1449-1461. PubMed ID: 36649165
[TBL] [Abstract][Full Text] [Related]
14. Favorable Survival After Screening for Young-Onset Colorectal Cancer: Benefits of Screening in Young Adults.
Takada K; Hotta K; Imai K; Ito S; Kishida Y; Ono H
Dis Colon Rectum; 2022 Aug; 65(8):996-1004. PubMed ID: 34856591
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Venous Invasion Detected by Elastin Stain May Surpass Lymph Node Status in Colon Cancer.
Kim HJ; Choi GS; Seo AN; Park JS; Park SY; Cho SH; Yoon G
Dis Colon Rectum; 2021 Aug; 64(8):955-963. PubMed ID: 33938533
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Extramural Lymphatic, Vascular, and Perineural Invasion in Stage II Colon Cancer: A Comparison With Intramural Invasion.
Cho SS; Park JW; Kang GH; Kim JH; Bae JM; Han SW; Kim TY; Kim MJ; Ryoo SB; Jeong SY; Park KJ
Dis Colon Rectum; 2023 Mar; 66(3):366-373. PubMed ID: 35333785
[TBL] [Abstract][Full Text] [Related]
17. Mediating Factors Between Race and Time to Treatment in Colorectal Cancer.
Grunvald MW; Underhill JM; Skertich NJ; Williams MD; Aquina CT; Bhama AR; Hayden DM; Becerra AZ
Dis Colon Rectum; 2023 Feb; 66(2):331-336. PubMed ID: 34933318
[TBL] [Abstract][Full Text] [Related]
18. Impact of Anastomotic Leak on Long-term Oncological Outcomes After Restorative Surgery for Rectal Cancer: A Retrospective Cohort Study.
Engel RM; Oliva K; Centauri S; Wang W; McMurrick PJ; Yap R
Dis Colon Rectum; 2023 Jul; 66(7):923-933. PubMed ID: 36538716
[TBL] [Abstract][Full Text] [Related]
19. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis.
You JF; Hsu YJ; Chern YJ; Hung HY; Hsieh PS; Yeh CY; Chiang JM; Tsai WS
Dis Colon Rectum; 2020 Jun; 63(6):796-806. PubMed ID: 32118625
[TBL] [Abstract][Full Text] [Related]
20. The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study.
Chang CY; Lin CC; Lin HH; Lan YT; Chang SC; Wang HS; Yang SH; Chen WS; Lin JK; Jiang JK
Dis Colon Rectum; 2023 Oct; 66(10):e1032-e1042. PubMed ID: 36538674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
